brompheniramine maleate 0.8 MG/ML / chlophedianol hydrochloride 5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution

RxCUI
1111065
RxNorm name
brompheniramine maleate 0.8 MG/ML / chlophedianol hydrochloride 5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution
Display name
Brompheniramine/Chlophedianol/Phenylephrine (Oral Liquid)
Full name
brompheniramine maleate 0.8 MG/ML / chlophedianol hydrochloride 5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution
Term type
SCD
Status
Active
Strength
4-25-10 mg/5ml
Dose form
Sol
Route
Oral Liquid
Updated
2026-06-15 07:03:55

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
072011
Active start
072011
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
brompheniramine maleate0.8 MG / 1 MLbrompheniraminebrompheniramine maleate
chlophedianol hydrochloride5 MG / 1 MLchlophedianolchlophedianol hydrochloride
phenylephrine hydrochloride2 MG / 1 MLphenylephrinephenylephrine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Solution316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
brompheniramine1767
chlophedianol21254
phenylephrine8163

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
64543050104rxnav_ndcsyes
64543050116rxnav_ndcsyes
64543050101rxnav_historical_indirect

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC01CAAdrenergic and dopaminergic agentsATC1-4phenylephrine
ATCC05AXOther agents for treatment of hemorrhoids and anal fissures for topical useATC1-4phenylephrine
ATCR05DBOther cough suppressantsATC1-4chlophedianol
ATCR06ABSubstituted alkylaminesATC1-4brompheniramine
ATCR01BASympathomimeticsATC1-4phenylephrine
ATCS01FBSympathomimetics excl. antiglaucoma preparationsATC1-4phenylephrine
ATCS01GASympathomimetics used as decongestantsATC1-4phenylephrine
ATCR01ABSympathomimetics, combinations excl. corticosteroidsATC1-4phenylephrine
ATCR01AASympathomimetics, plainATC1-4phenylephrine
FDASPLN0000186105alpha-1 Adrenergic AgonistEPChas_epcphenylephrine
MEDRTD001977BrompheniramineCHEMhas_ingredientbrompheniramine maleate
MEDRTD001977BrompheniramineCHEMhas_ingredientbrompheniramine
MEDRTD010656PhenylephrineCHEMhas_ingredientphenylephrine
MEDRTD010656PhenylephrineCHEMhas_ingredientphenylephrine hydrochloride
MEDRTD011412PropanolaminesCHEMhas_ingredientchlophedianol hydrochloride
MEDRTD011412PropanolaminesCHEMhas_ingredientchlophedianol
MEDRTD013447SulfitesCHEMci_chemclassphenylephrine
MEDRTD013447SulfitesCHEMci_chemclassphenylephrine hydrochloride
MEDRTD003139Common ColdDISEASEmay_treatbrompheniramine maleate
MEDRTD003139Common ColdDISEASEmay_treatbrompheniramine
MEDRTD003327Coronary DiseaseDISEASEci_withbrompheniramine
MEDRTD003327Coronary DiseaseDISEASEci_withbrompheniramine maleate
MEDRTD004342Drug HypersensitivityDISEASEci_withphenylephrine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withbrompheniramine
MEDRTD004342Drug HypersensitivityDISEASEci_withphenylephrine
MEDRTD004342Drug HypersensitivityDISEASEci_withbrompheniramine maleate
MEDRTD005401Fissure in AnoDISEASEmay_treatphenylephrine hydrochloride
MEDRTD005401Fissure in AnoDISEASEmay_treatphenylephrine
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withbrompheniramine
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withbrompheniramine maleate
MEDRTD005902Glaucoma, Open-AngleDISEASEmay_treatphenylephrine hydrochloride
MEDRTD005902Glaucoma, Open-AngleDISEASEmay_treatphenylephrine
MEDRTD006484HemorrhoidsDISEASEmay_treatphenylephrine hydrochloride
MEDRTD006484HemorrhoidsDISEASEmay_treatphenylephrine
MEDRTD006973HypertensionDISEASEci_withbrompheniramine maleate
MEDRTD006973HypertensionDISEASEci_withphenylephrine hydrochloride
MEDRTD006973HypertensionDISEASEci_withphenylephrine
MEDRTD006973HypertensionDISEASEci_withbrompheniramine
MEDRTD007022HypotensionDISEASEmay_treatphenylephrine
MEDRTD007022HypotensionDISEASEmay_treatphenylephrine hydrochloride
MEDRTD007415Intestinal ObstructionDISEASEci_withbrompheniramine maleate
MEDRTD007415Intestinal ObstructionDISEASEci_withbrompheniramine
MEDRTD015878MydriasisDISEASEinducesphenylephrine
MEDRTD015878MydriasisDISEASEinducesphenylephrine hydrochloride
MEDRTD010437Peptic UlcerDISEASEci_withbrompheniramine maleate
MEDRTD010437Peptic UlcerDISEASEci_withbrompheniramine
MEDRTD011538Pruritus AniDISEASEmay_treatphenylephrine hydrochloride
MEDRTD011538Pruritus AniDISEASEmay_treatphenylephrine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatbrompheniramine maleate
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatbrompheniramine
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatbrompheniramine maleate
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatphenylephrine
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatphenylephrine hydrochloride
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatbrompheniramine
MEDRTD012772Shock, SepticDISEASEmay_treatphenylephrine
MEDRTD012772Shock, SepticDISEASEmay_treatphenylephrine hydrochloride
MEDRTD013224Status AsthmaticusDISEASEci_withbrompheniramine maleate
MEDRTD013224Status AsthmaticusDISEASEci_withbrompheniramine
MEDRTD013617Tachycardia, SupraventricularDISEASEmay_treatphenylephrine
MEDRTD013617Tachycardia, SupraventricularDISEASEmay_treatphenylephrine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEci_withphenylephrine
MEDRTD017180Tachycardia, VentricularDISEASEci_withphenylephrine hydrochloride
MEDRTD014517Ureteral ObstructionDISEASEci_withbrompheniramine
MEDRTD014517Ureteral ObstructionDISEASEci_withbrompheniramine maleate
MEDRTD014522Urethral DiseasesDISEASEci_withbrompheniramine
MEDRTD014522Urethral DiseasesDISEASEci_withbrompheniramine maleate
MEDRTD014581UrticariaDISEASEmay_treatbrompheniramine maleate
MEDRTD014581UrticariaDISEASEmay_treatbrompheniramine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaphenylephrine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaphenylephrine hydrochloride
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moabrompheniramine
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moabrompheniramine maleate
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moabrompheniramine
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moabrompheniramine maleate
MEDRTN0000008371Conjunctival Arterial VasoconstrictionPEhas_pephenylephrine
MEDRTN0000008371Conjunctival Arterial VasoconstrictionPEhas_pephenylephrine hydrochloride
MEDRTN0000008383Decreased Acetylcholine ActivityPEhas_pebrompheniramine
MEDRTN0000008383Decreased Acetylcholine ActivityPEhas_pebrompheniramine maleate
MEDRTN0000008657Decreased Histamine ActivityPEhas_pebrompheniramine
MEDRTN0000008657Decreased Histamine ActivityPEhas_pebrompheniramine maleate
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_pephenylephrine
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_pephenylephrine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.8 MG/ML / 5 MG/ML (expressed as chlophedianol hydrochloride) / 2 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSCD
CODESMMSL_CODEBD27576
CODESMMSL_CODECD27576
CODESRxCUI1111065
NAMESPrescribable Synonymbrompheniramine maleate 4 MG / chlophedianol HCl 25 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution
NAMESRXNAV_STRbrompheniramine maleate 0.8 MG/ML / chlophedianol hydrochloride 5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution
NAMESRxNorm Namebrompheniramine maleate 0.8 MG/ML / chlophedianol hydrochloride 5 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution
NAMESRxNorm Synonymbrompheniramine maleate 4 MG / chlophedianol hydrochloride 25 MG / phenylephrine hydrochloride 10 MG per 5 ML Oral Solution
SOURCESSourceNational Drug Data File Plus Source Vocabulary